Peer Reviewed
Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
K’bria Whaley, PharmD Candidate
Advertisement
Articles by K’bria Whaley, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
3
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
4
Pharmacist Outreach Doubles SGLT2 Inhibitor Uptake in CKD
5